Literature DB >> 14977961

Epitope mapping of a protective monoclonal antibody against Pneumocystis carinii with shared reactivity to Streptococcus pneumoniae surface antigen PspA.

Jesse Wells1, Francis Gigliotti, Patricia J Simpson-Haidaris, Constantine G Haidaris.   

Abstract

Pneumocystis carinii is an opportunistic fungal pathogen that causes pneumonia in the immunocompromised host. A protective monoclonal antibody (MAb) termed 4F11 generated against mouse-derived P. carinii was shown by indirect immunofluorescence assay (IFA) to bind surface antigens of P. carinii derived from multiple host species, including humans. We have identified multiple epitopes recognized by MAb 4F11 in two recombinant mouse P. carinii antigens. The epitopes mapped have similar proline content and positive charge distribution. The consensus 8-mer epitope recognized by MAb 4F11 is K/RPA/RPK/QPA/TP. Immune sera raised against intact mouse P. carinii recognized native antigens affinity purified with MAb 4F11 and a recombinant antigen reactive with MAb 4F11. Database searches for short, nearly exact matches to the mapped MAb 4F11 epitopes identified a bacterial surface antigen, Streptococcus pneumoniae PspA, with a similar proline-rich region. In an IFA, MAb 4F11 detected antigens on the S. pneumoniae surface, and Western blotting identified a protein in S. pneumoniae lysates consistent with the M(r) of PspA. A fragment of the S. pneumoniae PspA gene was cloned and sequenced, and the deduced amino acid sequence contained a region with strong similarity to the MAb 4F11 epitopes identified in P. carinii. The PspA recombinant polypeptide was recognized by MAb 4F11 in a Western blot. The ability of MAb 4F11 to recognize similar proline-rich epitopes may explain its ability to recognize P. carinii derived from multiple hosts and will permit testing of the epitopes recognized by this antibody in immunization against P. carinii.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977961      PMCID: PMC356052          DOI: 10.1128/IAI.72.3.1548-1556.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  P.carinii host specificity: attempt of cross infections with human derived strains in rats.

Authors:  C Atzori; F Agostoni; E Angeli; A Mainini; V Micheli; A Cargnel
Journal:  J Eukaryot Microbiol       Date:  1999 Sep-Oct       Impact factor: 3.346

2.  Pillars article: approaching the asymptote? Evolution and revolution in immunology. Cold spring harb symp quant biol. 1989. 54: 1-13.

Authors:  Charles A Janeway
Journal:  J Immunol       Date:  2013-11-01       Impact factor: 5.422

3.  Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae.

Authors:  S K Hollingshead; R Becker; D E Briles
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 4.  Update on the epidemiology and transmission of Pneumocystis carinii.

Authors:  Alison Morris; C Ben Beard; Laurence Huang
Journal:  Microbes Infect       Date:  2002-01       Impact factor: 2.700

5.  Cell surface protease PRT1 identified in the fungal pathogen Pneumocystis carinii.

Authors:  E B Lugli; E T Bampton; D J Ferguson; A E Wakefield
Journal:  Mol Microbiol       Date:  1999-03       Impact factor: 3.501

6.  Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii.

Authors:  L H Lee; F Gigliotti; T W Wright; P J Simpson-Haidaris; G A Weinberg; C G Haidaris
Journal:  Gene       Date:  2000-01-25       Impact factor: 3.688

7.  Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia.

Authors:  Francis Gigliotti; Constantine G Haidaris; Terry W Wright; Allen G Harmsen
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

8.  Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae.

Authors:  W D Waltman; L S McDaniel; B M Gray; D E Briles
Journal:  Microb Pathog       Date:  1990-01       Impact factor: 3.738

9.  PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type.

Authors:  L S McDaniel; J S Sheffield; P Delucchi; D E Briles
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia.

Authors:  A Brooks-Walter; D E Briles; S K Hollingshead
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

View more
  12 in total

1.  Novel pneumocystis antigen discovery using fungal surface proteomics.

Authors:  Mingquan Zheng; Yang Cai; Taylor Eddens; David M Ricks; Jay K Kolls
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

2.  Complement and Fc function are required for optimal antibody prophylaxis against Pneumocystis carinii pneumonia.

Authors:  Jesse Wells; Constantine G Haidaris; Terry W Wright; Francis Gigliotti
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  An improved and robust DNA immunization method to develop antibodies against extracellular loops of multi-transmembrane proteins.

Authors:  Meredith Hazen; Sunil Bhakta; Rajesh Vij; Steven Randle; Dara Kallop; Vicki Chiang; Isidro Hötzel; Bijay S Jaiswal; Karen E Ervin; Bing Li; Robby M Weimer; Paul Polakis; Richard H Scheller; Jagath R Junutula; Jo-Anne S Hongo
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

Review 4.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

5.  Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen.

Authors:  Jesse Wells; Constantine G Haidaris; Terry W Wright; Francis Gigliotti
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 6.  A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Authors:  Liang Ma; Ousmane H Cissé; Joseph A Kovacs
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

7.  Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii.

Authors:  Brenda L Tesini; Terry W Wright; Jane E Malone; Constantine G Haidaris; Martha Harber; Andrea J Sant; Jennifer L Nayak; Francis Gigliotti
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

8.  Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.

Authors:  Jing Wang; Francis Gigliotti; Samir P Bhagwat; Thaddeus C George; Terry W Wright
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

9.  Combination Immunotherapy with Passive Antibody and Sulfasalazine Accelerates Fungal Clearance and Promotes the Resolution of Pneumocystis-Associated Immunopathogenesis.

Authors:  Zachary Hoy; Terry W Wright; Michael Elliott; Jane Malone; Samir Bhagwat; Jing Wang; Francis Gigliotti
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441

10.  Immunization with Pneumocystis carinii A121-85 antigen activates immune function against P. carinii.

Authors:  Tong Tong; Zhongxin Wang; Yuanhong Xu; Jilu Shen
Journal:  BMC Immunol       Date:  2021-06-27       Impact factor: 3.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.